- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Novartis' expenditure on research and development 2004-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Novartis' expenditure on research and development 2004-2018
Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Jan 30, 2019
This statistic shows the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2018. Novartis AG is one of the world's largest pharma companies. In 2004, Novartis spent approximately four billion U.S. dollars on research and development.
Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)
| Expenditure in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Expenditure in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 30, 2019
This statistic shows the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2018. Novartis AG is one of the world's largest pharma companies. In 2004, Novartis spent approximately four billion U.S. dollars on research and development.
- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- 2004 to 2018
- Supplementary notes
-
This statistic was assembled from several annual reports.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- 2004 to 2018
- Supplementary notes
-
This statistic was assembled from several annual reports.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015. - Open this statistic in...
Other statistics on the topic
Novartis
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Novartis' top drugs based on revenue 2018
+Pharmaceutical Products & Market
R&D spending share of top pharmaceutical companies 2018 and 2024
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Novartis
- 46 page/s
- English
- pptx
- Detailed references
Everything On "Novartis" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Novartis"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*R&D spending share of top pharmaceutical companies 2018 and 2024
- Net profit per employee of global top pharmaceutical companies in 2017 (in 1,000 U.S. dollars)Net profit generated per employee in top pharmaceutical companies 2017
- Company overview
The most important statistics
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)Novartis' net income 2007-2018
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2018
- Total number of Novartis AG's full-time employees from 2009 to 2018*Novartis' number of full-time employees 2009-2018
- Revenue distribution
The most important statistics
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)Novartis' revenue by region 2016-2018
- Percentage of Novartis AG's revenue in 2018, by segment and market*Novartis - revenue 2018 by segment and market
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Research and development
The most important statistics
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2018
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)Novartis' spending on research and development by division 2017-2018
- Miscellaneous
The most important statistics
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)Patients reached by Novartis AG's products 2009-2018
- Novartis advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Novartis' sales revenue in Spain 2012-2017
- Novartis' number of full-time employees by division 2013-2014
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Italy: value of taxes paid by Novartis 2013-2017
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: investments of Novartis 2013-2017
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: value of purchased goods and services of Novartis 2017, by region
- Italy: distribution of employees of Novartis 2017, by gender
- Italy: investments of Novartis in research and development 2013-2017
- Italy: number of employees of Novartis 2017, by region
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Top pharmaceutical companies by sales and R&D spending 2011
- Industry revenue of »research on social sciences and humanities« in Czechia 2011-2023
- Industry revenue of »research on social sciences and humanities« in Spain 2011-2023
- Research on social sciences and humanities revenue in Finland 2010-2022
- Industry revenue of »research on social sciences and humanities« in Italy 2011-2023
- Research on social sciences and humanities revenue in France 2010-2022
Studies
- Biotechnology Industry in Europe
- Pharmaceutical industry in Italy
- The State of Innovation in Highly Prevalent Chronic Diseases 2019
- Animal testing in the United Kingdom
- Putting the Science back into Life Sciences
- Unleashing Pharma from the R&D Value Chain
- Public Attitudes to Animal Research in 2016
- 2019 PhRMA Annual Membership Survey
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- California Life Sciences Industry Report 2019
- The 2019 Genentech Oncology Trend Report
- PhRMA 2014 Biopharmaceutical Research Industry Profile
- Life Sciences Outlook United States 2017
- PhRMA 2015 Biopharmaceutical Research Industry Profile
- PhRMA 2016 Biopharmaceutical Research Industry Profile
Statistics on "Novartis"
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*
- Net profit per employee of global top pharmaceutical companies in 2017 (in 1,000 U.S. dollars)
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)
- Total number of Novartis AG's full-time employees from 2009 to 2018*
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)
- Percentage of Novartis AG's revenue in 2018, by segment and market*
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)
- Novartis advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)
- Annual turnover of Novartis in Spain from 2012 to 2017 (in million euros)
- Number of Novartis AG's full-time employees in 2013 and 2014, by division
- Contribution of Novartis AG's growth products to pharmaceutical revenue from 2009 to 2016*
- Value of taxes paid by the pharmaceutical company Novartis in Italy from 2013 to 2017 (in million euros)
- Distribution of clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area
- Investments of pharmaceutical company Novartis in Italy from 2013 to 2017 (in million euros)
- Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage
- Patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by region (per 100,000 inhabitants)
- Value of purchased goods and services of pharmaceutical company Novartis in Italy in 2017, by region (in million euros)
- Distribution of employees of the pharmaceutical company Novartis in Italy in 2015 and 2017, by gender
- Investments of pharmaceutical company Novartis in research and development in Italy from 2013 to 2017 (in million euros)
- Number of employees of the pharmaceutical company Novartis in Italy in 2017, by region
- Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area
- Top 10 pharmaceutical companies by prescription sales and R&D spending in 2011 (in billion U.S. dollars)*
- Industry revenue of »research on social sciences and humanities« in Czechia from 2011 to 2023 (in million U.S. Dollars)
- Industry revenue of »research on social sciences and humanities« in Spain from 2011 to 2023 (in million U.S. Dollars)
- Research on social sciences and humanities revenue in Finland from 2010 to 2022 (in million U.S. dollars)
- Industry revenue of »research on social sciences and humanities« in Italy from 2011 to 2023 (in million U.S. Dollars)
- Research on social sciences and humanities revenue in France from 2010 to 2022 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.